Enter your login e-mail to the account
Search
- Psychosocial aspects of active surveillance for prostate cancer
doc. MUDr. Otakar Čapoun, Ph.D., FEBU
(2/2025, Review articles ) - Emerging trends in telemedicine and artificial intelligence in urology
MUDr. Martin Malý, MUDr. Alžběta Kantorová, doc. MUDr. David Zogala, Ph.D., doc. MUDr. Otakar Čapoun, Ph.D., FEBU, prof. MUDr. Viktor Soukup, Ph.D., FEBU, MHA
(2/2025, Review articles ) - Therapy of prostate cancer in elderly patients
MUDr. Otakar Čapoun, Ph.D., FEBU
(3/2022, Review articles ) - Diagnostic algorithms in prostate cancer – 2nd part
MUDr. Otakar Čapoun, Ph.D., FEBU
(3/2021, In short ) - Diagnostic algorithms in prostate cancer – 1st part
MUDr. Otakar Čapoun, Ph.D., FEBU
(2/2021, In short ) - Prostate rebiopsy: when should be performed?
MUDr. Otakar Čapoun, Ph.D., FEBU
(3/2020, Practical advice ) - New treatment options in hormone-sensitive prostate cancer
MUDr. Otakar Čapoun, Ph.D., FEBU
(5/2019, Review articles ) - Androgen deprivation therapy of prostate cancer and cardiovascular morbidity
MUDr. Otakar Čapoun, Ph.D., FEBU
(4/2019, Review articles ) - Effectiveness and safety of abiraterone acetate treatment for metastatic castration-resistant prostate cancer post-chemotherapy
MUDr. Tomáš Hradec, FEBU, MUDr. Otakar Čapoun, FEBU
(2/2018, Review articles ) - Systemic radiotherapy for prostate cancer with bone metastases
MUDr. Otakar Čapoun, FEBU
(3/2016, Review articles )













